SPC254

Tisagenlecleucel

  • Status:
    Veitt
  • Application date:
    15.2.2019
  • Application published:
    15.3.2019
  • Grant published:
    15.9.2020
  • Max expiry date:
    26.8.2033
  • Medicine name:
    Kymriah
  • Medicine for children:
    No

Timeline

Today
15.2.2019Application
15.3.2019Publication
15.9.2020Registration
26.8.2033Expires

Marketing license

  • IS authorization number:
    EU/1/18/1297/001
  • Date:
    21.9.2018
  • Foreign authorization number:
    EU/1/18/1297
  • Date:
    23.8.2018

Owner

  • Name:
    The Trustees of The University of Pennsylvania
  • Address:
    Center for Technology Transfer 3160 Chestnut Street, Suite 200, Philadelphia US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents